Advertisement

FSAP, a new player in inflammation?

Journal:Hämostaseologie
ISSN:0720-9355
DOI:http://dx.doi.org/10.5482/ha-1187
Issue:Issues of 2012 (Vol. 32): Issue 1 2012 (1-86)
Pages:51-55

FSAP, a new player in inflammation?

F. Stephan (1), L. A. Aarden (1), S. Zeerleder (1, 2)

(1) Department of Immunopathology, Sanquin Research and Landsteiner Laboratory AMC, Amsterdam, the Netherlands; (2) Department of Haematology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands

Summary

Factor VII-activating protease (FSAP) is a serine protease in plasma that has a role in coagulation and fibrinolysis. FVII could be activated by purified FSAP in a tissue factor independent manner and pro-urokinase has been demonstrated to be a substrate for purified FSAP in-vitro. However, the physiological role of FSAP in haemostasis remains unclear. More recently FSAP is suggested to be involved in inflammation. It modulates vascular permeability directly and indirectly by the generation of bradykinin. Furthermore, FSAP is activated by dead cells induced by the inflammatory response and subsequently removes nucleosomes from apoptotic cells. FSAP activation can be detected in sepsis patients as well. However, whether FSAP activation upon inflammation is beneficial or detrimental remains an open question. In this review the structure, activation mechanisms and the possible role of FSAP in inflammation are discussed.

Keywords

inflammation, Factor VII-activating protease, hyaluronic acid binding protein 2, nucleosomes

DOI

http://dx.doi.org/10.5482/ha-1187

You may also be interested in...

1.

Helene Hochart1, P. Vincent Jenkins1,2, Roger J. S. Preston1, Owen P. Smith3, Barry White1,2, James O’Donnell1,2

Thrombosis and Haemostasis 2008 99 3: 570-575

http://dx.doi.org/10.1160/TH07-06-0424

2.

Didier Hanriot1,2*, Gaëlle Bello1,2*, Armelle Ropars1,2, Carole Seguin-Devaux5, Gaël Poitevin1,2, Sandrine Grosjean3, Véronique Latger-Cannard2,3,4, Yvan Devaux1,2,5, Faiez Zannad1,2, Véronique Regnault2,4, Patrick Lacolley1,2, Paul-Michel Mertes1,2, Ketsia Hess*1,2, Dan Longrois*1,2

Thrombosis and Haemostasis 2008 99 3: 558-569

http://dx.doi.org/10.1160/TH07-06-0410

3.

Laura Barberis, Emilio Hirsch

Thrombosis and Haemostasis 2008 99 2: 279-285

http://dx.doi.org/10.1160/TH07-10-0632